This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
iot: Archive
3 Instruments Stocks Set to Ride Against Industry Headwinds
by Supriyo Bose
The increasing adoption of industrial automation, focus on higher energy efficiency and optimum resource utilization should drive the Zacks Instruments ??? Control industry. WWD, WTS and THR are well-positioned to gain from the evolving market dynamics.
WWDPositive Net Change WTSNegative Net Change THRNegative Net Change
artificial-intelligence auto-tires-trucks automation industrial-products iot tech-stocks
Will Soft Processor Revenues Affect Intel's Q3 Earnings?
by Zacks Equity Research
INTC is likely to have recorded lower revenues from the CCG segment due to high customer inventory levels and a conservative approach toward placing orders for high-value items.
INTCNegative Net Change QCOMNegative Net Change ANETNegative Net Change ATUSNegative Net Change
artificial-intelligence cloud-computing computers earnings iot semiconductor tech-stocks
3 Telecom Stocks Likely to Outpace Q3 Earnings Estimates
by Supriyo Bose
ANET, ATUS and QCOM are poised to benefit from higher demand for scalable infrastructure for seamless connectivity.
QCOMNegative Net Change ANETNegative Net Change ATUSNegative Net Change
cloud-computing communications earnings iot mobile tech-stocks
INTC Stock Before Q3 Earnings Release: To Buy or Not to Buy?
by Supriyo Bose
With declining earnings estimates and abysmal price performance, INTC is witnessing a negative investor perception.
AMZNPositive Net Change INTCNegative Net Change AMDNegative Net Change IBMNegative Net Change NVDANegative Net Change
artificial-intelligence cloud-computing communications computers earnings-preview iot semiconductor tech-stocks
IBM's Q3 Earnings Beat, Revenues Miss Despite Solid Demand
by Zacks Equity Research
Healthy demand trends for hybrid cloud and AI solutions with a broad-based growth help IBM to beat third-quarter 2024 earnings estimate.
IBMNegative Net Change AKAMNegative Net Change ANETNegative Net Change PINSPositive Net Change
artificial-intelligence cloud-computing computers earnings iot tech-stocks
Should You Buy Marriott International (MAR) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
MARPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
T's Q3 Earnings Beat, Revenues Miss Despite Wireless Traction
by Zacks Equity Research
Backed by strong subscriber growth with 5G and fiber focus, AT&T beats third-quarter 2024 earnings estimates.
TNegative Net Change AKAMNegative Net Change ANETNegative Net Change PINSPositive Net Change
artificial-intelligence auto-tires-trucks communications earnings iot mobile tech-stocks
Ardagh Metal Packaging S.A. (AMBP)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AMBPNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Nayax (NYAX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
NYAXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
VZ Beats on Q3 Earnings, Revenues Miss Despite Wireless Traction
by Zacks Equity Research
Healthy wireless traction helped Verizon to beat third-quarter 2024 earnings estimate.
VZNegative Net Change AKAMNegative Net Change ANETNegative Net Change PINSPositive Net Change
artificial-intelligence auto-tires-trucks communications earnings iot mobile tech-stocks
3 Tech Stocks to Watch as Q3 Earnings Approach: CSGP, IBM, VRT
by Shaun Pruitt
Led by International Business Machines (IBM), several trending tech stocks are set to report their third quarter results on Tuesday, October 22.
IBMNegative Net Change CSGPPositive Net Change VRTNegative Net Change
cloud-computing computers earnings internet investing iot tech-stocks
Southwest Airlines (LUV) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
LUVPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
McEwen (MUX) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
MUXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Scholar Rock Holding Corporation (SRRK) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
SRRKNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will Higher Software Revenues Benefit IBM's Earnings in Q3?
by Zacks Equity Research
IBM is likely to have recorded higher revenues from the Software segment on product innovation and the growing clout of watsonx.ai.
IBMNegative Net Change GLWNegative Net Change PYPLNegative Net Change UBERPositive Net Change
artificial-intelligence auto-tires-trucks cloud-computing communications computers iot tech-stocks
Will Solid Consulting Revenues Boost IBM's Q3 Earnings?
by Zacks Equity Research
IBM is likely to have recorded higher revenues from the Consulting segment backed by rising demand for technology consulting and business transformation services.
IBMNegative Net Change GLWNegative Net Change PYPLNegative Net Change UBERPositive Net Change
artificial-intelligence auto-tires-trucks computers iot tech-stocks
AT&T (T) Stock Before Q3 Earnings Release: To Buy or Not to Buy?
by Supriyo Bose
By investing in infrastructure and pioneering new technologies, T is well-positioned to enhance the connectivity landscape nationwide.
TNegative Net Change VZNegative Net Change ORCLPositive Net Change TMUSNegative Net Change
artificial-intelligence auto-tires-trucks communications earnings-preview iot mobile tech-stocks telecom
REE Automotive Ltd. (REE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
REENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Amicus Therapeutics (FOLD) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
FOLDPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Verizon Pre-Q3 Earnings: Is VZ Stock a Portfolio Must-Have?
by Supriyo Bose
VZ is well-positioned to bridge the digital divide and enhance the connectivity landscape nationwide with steady infrastructure investments.
TNegative Net Change VZNegative Net Change TMUSNegative Net Change
artificial-intelligence auto-tires-trucks communications iot mobile tech-stocks telecom
IBM Stock Before Q3 Earnings Release: To Buy or Not to Buy?
by Supriyo Bose
IBM is poised to benefit from strong demand for hybrid cloud and AI, driving growth in the Software and Consulting segments.
MSFTPositive Net Change IBMNegative Net Change ORCLPositive Net Change
artificial-intelligence automation cloud-computing computers iot software tech-stocks
Should QCOM Stock Be in Your Portfolio on Intel Takeover Speculations?
by Supriyo Bose
Qualcomm appears to be treading in the middle of the road and investors could be better off if they trade with caution.
INTCNegative Net Change QCOMNegative Net Change AVGONegative Net Change HPEPositive Net Change
artificial-intelligence autonomous-vehicles communications computers iot mobile semiconductor tech-stocks telecom
Will Celestica's Latest Portfolio Expansion Buoy CLS Stock?
by Supriyo Bose
CLS appears to be treading in the middle of the road and new investors could be better off if they trade with caution.
JBLNegative Net Change FLEXPositive Net Change CLSNegative Net Change AVGONegative Net Change
artificial-intelligence auto-tires-trucks automation communications electronics iot tech-stocks
After Golden Cross, HCI Group (HCI)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
HCINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will ASTS' Ploy to Connect Directly to User Mobiles Aid the Stock?
by Supriyo Bose
ASTS appears to be treading in the middle of the road and new investors could be better off if they trade with caution.
TNegative Net Change VZNegative Net Change AVNWNegative Net Change CMTLNegative Net Change ASTSNegative Net Change
artificial-intelligence auto-tires-trucks communications iot mobile tech-stocks telecom